Incyte (INCY) Accumulated Expenses (2010 - 2026)
Incyte's Accumulated Expenses came in at $870.31 million for Q2 2026, up 1.5% from $857.09 million a year earlier but down 20.3% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Incyte's Accumulated Expenses was $1.03 billion, down 14.9% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $1.21 billion in FY2024 (+29.6%), $935.57 million in FY2023 (+33.5%), $701.05 million in FY2022 (+31.4%) and $533.6 million in FY2021 (+41.0%).
- The five-year range for quarterly Accumulated Expenses is $481.88 million (Q3 2021) to $1.38 billion (Q1 2025).
- Year-over-year, Accumulated Expenses increased in four of the last eight quarters, with growth averaging 3.1%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2022 (growth of 45.2%), and the weakest in Q1 2026 (a decline of 20.6%).
- Business Quant data shows INCY's Accumulated Expenses at $1.09 billion (Q1 2026), $1.03 billion (Q4 2025) and $948.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Incyte | 23.54 Bn | 8.48 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 870.31 Mn |
| Mar 31, 2026 | 1.09 Bn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 948.44 Mn |
| Jun 30, 2025 | 857.09 Mn |
| Mar 31, 2025 | 1.38 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 935.57 Mn |
| Sep 30, 2023 | 820.61 Mn |
| Jun 30, 2023 | 810.85 Mn |
| Mar 31, 2023 | 825.44 Mn |
| Dec 31, 2022 | 701.05 Mn |
| Sep 30, 2022 | 699.81 Mn |
| Jun 30, 2022 | 598.81 Mn |
| Mar 31, 2022 | 609.29 Mn |
| Dec 31, 2021 | 533.60 Mn |
| Sep 30, 2021 | 481.88 Mn |
API Access
Incyte Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();